Fingerprint
Dive into the research topics of 'Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sanne C.F.A. Huijberts*, Robin M.J.M. Van Geel, Rene Bernards, Jos H. Beijnen, Neeltje Steeghs*
Research output: Contribution to journal › Article › Academic › peer-review